Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
Thrombosis and Haemostasis|January 29, 2016
The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort studyGualtiero Palareti, Emilia Antonucci, Gregory Y H Lip, et al.
Thrombosis Research|April 26, 2024
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical resultsGualtiero Palareti, Cristina Legnani, Alberto Tosetto, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 7, 2005
Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulationAngelo Ramondo, Giuseppe Maiolino, Massimo Napodano, et al.
Thrombosis and Haemostasis|September 6, 2006
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidityAmelia Ruffatti, Marta Tonello, Teresa Del Ross, et al.
Plos One|August 17, 2013
Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAsLeonie Pelkmans, Hilde Kelchtermans, Philip G de Groot, et al.
Giornale Italiano Di Cardiologia (2006)|June 20, 2020
[Antithrombotic treatments in patients with SARS-CoV-2 infection: from current evidence to reasonable recommendations - A position paper from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology]Giuseppe Patti, Veronica Lio, Ilaria Cavallari, et al.
Thrombosis Research|June 16, 2012
Biological variation of INR in stable patients on long-term anticoagulation with warfarinAnton M H P van den Besselaar, Paola Fogar, Vittorio Pengo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 4, 2020
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular BiologyGiuseppe Patti, Veronica Lio, Ilaria Cavallari, et al.
Clinical Chemistry and Laboratory Medicine|April 1, 2024
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrenceVittorio Pengo, Luca Sarti, Emilia Antonucci, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 20, 2007
Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP)Vittorio Pengo, Gualtiero Palareti, Umberto Cucchini, et al.
Pageof 25